These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27531286)

  • 1. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
    Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
    Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
    Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
    Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C; Salsini G; Perri P
    Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.
    Silverstein SM; Cable MG; Sadri E; Peace JH; Fong R; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Curr Med Res Opin; 2011 Sep; 27(9):1693-703. PubMed ID: 21751945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
    Song SH; Baek SK; Lee MW; Lee YH
    Korean J Ophthalmol; 2020 Feb; 34(1):46-55. PubMed ID: 32037749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
    Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Findl O; Murta JCN; Goslings WRO; Tassignon MJ; Joosse MV; Henry YP; Rulo AHF; Güell JL; Amon M; Kohnen T; Nuijts RMMA;
    J Cataract Refract Surg; 2018 Apr; 44(4):429-439. PubMed ID: 29778106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.
    Hoy SM
    Clin Drug Investig; 2015 Aug; 35(8):525-9. PubMed ID: 26177719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Levitz L
    J Cataract Refract Surg; 2016 Dec; 42(12):1852. PubMed ID: 28007131
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.
    De Maria M; Coassin M; Mastrofilippo V; Cimino L; Iannetta D; Fontana L
    Adv Ther; 2020 Jul; 37(7):3223-3233. PubMed ID: 32440977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2 regimens of loteprednol etabonate and bromfenac for cataract surgery.
    Al-Awadi A; Tokko HA; Chan CC; Somani S
    Can J Ophthalmol; 2019 Jun; 54(3):388-394. PubMed ID: 31109481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The systemic safety of bromfenac ophthalmic solution 0.09%.
    Stewart RH; Grillone LR; Shiffman ML; Donnenfeld ED; Gow JA;
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):601-12. PubMed ID: 18001250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of postoperative administration of nonsteroidal antiinflammatory drugs and steroids on the conformational changes in wound healing after cataract surgery.
    Choi EY; Kang HG; Kim TI; Kim EK; Lee HK
    J Cataract Refract Surg; 2016 Dec; 42(12):1804-1813. PubMed ID: 28007113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.